What is the AVAC GPP Initiative?
AVAC works with partners on a wide array of initiatives to implement GPP in the research context. These activities trainings for trial site staff and civil society and ongoing support for country-led work plans that facilitate adaptation and implementation at a national level. Specific examples of recent collaborative work include:
- Wits Reproductive Health and HIV Initiative in South Africa is implementing GPP as a core component of FACTS 001, a confirmatory efficacy trial of tenofovir gel
- Uganda National Council for Science and Technology is incorporating GPP into its national research ethics guidelines
- Thai NGO Coalition on AIDS is working on GPP implementation with research centers throughout Thailand and has formed a national CAB
AVAC's GPP Partners
Our ongoing work builds on partnerships launched in 2008, when AVAC began working with biomedical HIV prevention stakeholders, including community groups, trial sites and NGOs to generate broader stakeholder feedback on opportunities, obstacles and additional needs of organizations, including civil society groups, interested in using GPP. These "GPP Partners" worked with AVAC to conduct consultative meetings, interviews, focus group discussions and other activities, helping to pilot and gain critical feedback on the GPP guidelines. Their input helped shape the second edition of GPP and is continuing to support national GPP implementation in some countries.
- Asociacion Civil Selva Amazonica, Peru
- Centre for the AIDS Programme of Research in South Africa (CAPRISA), South Africa
- Community Education Group, Inc. (CEG), United States
- Grupo de Incentivo a Vida (GIV) with Unidade de Pesquisa de Vacina Anti-HIV (UPSP), Brazil
- Kenya AIDS NGOs Consortium (KANCO) with Kenya AIDS Vaccine Initiative (KAVI) and the University of Nairobi Centre for HIV Prevention & Research (UoN-CHIVPR), Kenya
- Makerere University - Walter Reed Project (MUWRP), Uganda
- National AIDS Education & Services for Minorities, Inc. (NAESM), United States
- New HIV Vaccine and Microbicide Advocacy Society (NHVMAS), Nigeria
- Perinatal HIV Research Unit (PHRU), South Africa
- Planeta Salud, Spain
- Sex Workers Project at the Urban Justice Center, United States
- Thai AIDS Treatment Action Group (TTAG), Thailand
View our poster presented at AIDS Vaccine 2009 about the GPP partner consultations, Investigating the utility and relevance of the good participatory practice guidelines for biomedical HIV prevention trials.
GPP Baseline Survey
In 2009 AVAC conducted a baseline survey on GPP awareness with stakeholders of biomedical HIV prevention research, including trial sponsors and networks, trial site staff, community members and regulators. The findings show initial awareness and utilization of the GPP guidelines, assess attitudes around community engagement in biomedical HIV prevention trials and identify gaps in achieving appropriate community engagement. Good Participatory Practice (GPP) Guidelines Begin to Take Root is a poster, presented at AIDS Vaccine 2009, Paris, about the survey.